KL-6 is a salivary liquefied glycoprotein, primarily expressed on the surface of type II alveolar epithelial cells, and has been widely confirmed to be correlated with the development and progression of ILD (54–56), similar to the correlation between KL-6 and lung involvement shown in our study. The gene discussed is MUC1; the disease is interstitial lung disease.